Delivery Order SPE2DB22D1106-SPE2DB24FEBC9
Award Date 2/21/24
Potential Completion Date 2/22/24
Potential Value $3.1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $10,908.77 Firm Fixed Price Delivery Order from the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of GLYCOPYRROLATE INJECT medication with a completion date of July 20, 2023. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of GLYCOPYRROLATE 0.2 MG/ML VIAL 5ML, a specialty medication. The $22,051.67 firm fixed-price delivery order has a completion date of June 17, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of GLYCOPYRROLATE INJECT, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a delivery order with a firm fixed price of $8,856.68 and a completion date of May 25, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide glycopyrrolate 4 mg/20 ml vials. The contract, valued at $1,366.76, is a firm fixed-price delivery order with a completion date of May 28, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $7,774.29, is a firm fixed price delivery order for the supply of GLYCOPYRROLATE INJECT, a pharmaceutical product, with a period of performance through July 7, 2023. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,377.50 Firm Fixed Price delivery order is for the supply of GLYCOPYRROLATE INJECT, a medication used to treat certain conditions. The contract has an ultimate completion date of August 15, 2024. Amerisourcebergen, through its Corporate Office division, is the prime contractor and there is no set-aside designation. This award...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,252.97 firm-fixed-price delivery order is for the supply of GLYCOPYRROLATE INJECT, a pharmaceutical product, with a completion date of August 9, 2024. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the U.S. federal government, including military treatment facilities and veterans' hospitals....
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply the U.S. Department of Defense (DoD) and other government agencies with a specific medication, glycopyrrolate 0.2 mg/ml vial 20ml. The contract, valued at $2,704.75, is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award, SPE2DB20D7059|SPE2DB25FPWL4, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,495.04 fixed-price delivery order is for the supply of 4,566,696,580 units of the medication Glycopyrrolate 1 mg/5 ml vial. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of GLYCOPYRROLATE INJECT, a pharmaceutical product, to support the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $3,521.36 and is a Firm Fixed Price Delivery Order with a completion date of July 15, 2024. There is no set-aside designation indicated for this award. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous...